Drug Channels

Have you ever wondered where spammers get their counterfeit Viagra? Or why U.S. Senators don’t care? If so, then you should check out The Ph...

Today’s Wall Street Journal has a very good overview of key issues for the generic industry, such as biogenerics and the FDA’s generic appro...

Does anyone still believe that Wal-Mart will not shake up the pharmacy industry? Wal Mart Stores Inc (WMT) just expanded its $4 generic prog...

I don't normally agree with the New York Times editorial page, but it looks like they agree with me. On Monday morning, I posted CMS as ...

I’m blogging to you live from my hotel at the NACDS/HDMA RFID conference so I can opine real-time on the FDA’s hot-off-the-press pedigree d...

Today's Wall Street Journal has a great editorial by Alain Enthoven and Kyna Fong on the Democrats' plan to push for direct negotiat...

The CVS Corp (CVS) - Caremark Rx Inc (CMX) deal is raising many as-yet-unanswered questions about the timing of the deal. Today’s Wall Stree...

Yesterday’s CVS Corp (CVS) - Caremark Rx Inc (CMX) deal led to a record traffic day here at Drug Channels as investors and the industry scra...

Big news this morning! CVS Corp. (CVS) and Caremark Rx Inc (CMX) are now discussing a "merger of equals." See CVS, Caremark Rx Hol...

Although everyone is focused on the mid-term elections, pharmaceutical and medical products manufacturers should be paying attention to PDMA...

A number of people have asked me to follow-up on my AWP Ain’t What Matters post with additional comments on the proposed First DataBank AWP...

Halloween came a little early to the pharmaceutical industry today. The New York Times has an article called Confident Democrats Draft Broad...